Merck
Pays $400 Million In National Medicaid Fraud Settlement;
New Investigation
Model Ends Seven-Year Qui Tam Whistleblower Case

Home

Medicaid & The States

About
Medicaid

Rebate
Act & Best Price

How
Best Price Is Reported

The Case

Our News Release

Introduction

The
Company

The
Nevada Case

The Allegations

MD
Kickbacks

Consultant
Meetings

Free
Drug Kickbacks

Best
Price

The New
Model

The Attorneys

Steven
Cohen

Mark
Kleiman

BethAnne
Yeager

Timeline: A
Seven-Year Ordeal

Federal Case Documents

EDPA Complaint

EDPA Settlement Agreement

EDPA CIA

EDPA Orders

EDPA Notice of Intervention

EDPA Stipulation of Dismissal

The Drugs

The Drugs

Drug
Expert Greg Hamilton, Sr.

Whistleblowers

$20
Billion-Plus Recovered

Federal,
State and Local Laws

Industries,
Goods & Services

News & Info

Our News Release

USDOJ Release

EDPA Release

States

Company

Other News and Blogs

Glossary

Taxpayers Against Fraud

About Taxpayers
Against Fraud

Our
Attorneys & TAF

TAF Web site

Landmarks and Firsts

First
Government recovery from investigation into marketing of Zocor® and
Vioxx®.

First
fully-coordinated whistleblower-federal-state Medicaid fraud
investigation.

First
Medicaid fraud enforcement in which the States, lead by Nevada, tested
an innovative prosecution theory.

First
Federal and state nominal price Medicaid fraud
settlement.

The Case

Between 1998 and 2004, Merck employed several schemes with doctors and
hospitals to defraud Medicaid and maintain market share for Vioxx®, the
discontinued arthritis drug, and Zocor®, the statin whose patent
protection expired in 2006, it was alleged.

When Dean Steinke, a Merck district sales manager, was unable to get
management to stop its improper drug marketing tactics, he brought
evidence to a team of experienced qui tam whistleblower attorneys.
They took his case under seal to federal and state Governments.

After seven years of investigation and litigation, it was settled
today, returning more than $400 million to federal and state taxpayers. Read More

The New Model

Experienced qui tam whistleblower attorneys helped foster the
first fully-coordinated federal-state investigation. State and federal
prosecutors worked side-by-side with the whistleblower and his attorneys,
presenting Merck with a formidable, united front. Read
More

Seven-Year Timeline

The whistleblower and his attorneys, with federal and state
prosecutors, conducted a seven-year
investigation that produced the second largest Medicaid drug fraud
civil settlement in the history of the False Claims Act.

Qui Tam Whistleblowers

More than $20 billion has been recovered in federal civil actions under
the False Claims Act since the statute was amended in 1986 to provide
enhanced rewards and protections for qui tam whistleblowers. Read
More

Contact PRforLAW, LLC

Members of the media, state PIOs, use this short contact
form. On deadline? Call PRforLAW, LLC at 215-736-0198.

The Attorneys

Steven
H. Cohen
Mark
Kleiman
BethAnne
Yeager

Contact PRforLAW, LLC
| Legal Notices and
Disclaimers

©
Copyright 2008 PRforLAW.
LLC. All rights reserved. This Web site and any of its pages may not be
copied, electronically stored or deep linked without written permission from us.
In the case of material we have reprinted with permission, contact the copyright
holder of that document/work. Inactive links represent expected data not yet
received.